Crystal3 Labs acquired by Vithalbhai Dhaduk

Monday, December 19, 2011 10:42 AM

Crystal3 Labs, a cGMP contract research organization based in Boca
Raton, FL, has been acquired by an individual investor, Vithalbhai Dhaduk, M.D., of Fargo, ND. Financial terms of the transaction were not disclosed. The company will also change its name to Global Pharma Analytics.

Founded in 2007, Global Pharma Analytics provides pharmaceutical research
services and analytical testing of drugs and medical devices for the pharmaceutical and biotechnology industries. The company employs 6 people
in Florida.

Dr. Dhaduk serves as chairman of several biotech companies he cofounded. He is also an actively practicing neurologist and is currently chief of neurology at the Community Medical Center in Scranton, PA.

"Our name change reflects our increased investment in developing CRO services to meet the needs of pharmaceutical and biotechnology companies conducting research around the world. We look forward to working closely with Dr. Dhaduk, as his wisdom and extensive industry experience will be very valuable to us and to our clients,"  said Satish Chandran, Ph.D., chief executive officer at Global Pharma.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs